Salem Investment Counselors’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
MOS
AWM
JIC
AWM
SS
EWA
TWC
MG
SWA
Salem Investment Counselors's FLNA Position: Q2 2026 in Review
Salem Investment Counselors held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 275 shares worth $328. The position accounts for ﹤0.01% of the portfolio, ranked #1202.
Salem Investment Counselors first reported a position in FLNA in Q3 2022 and has held it in 15 quarters since. The position peaked at $12K in Q3 2022. 19 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.
- Salem Investment Counselors held 275 shares of Filana Therapeutics worth $328 as of Q2 2026.
- Salem Investment Counselors left its Filana Therapeutics share count unchanged in Q2 2026.
- Filana Therapeutics made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1202 holding.
- Salem Investment Counselors first reported a position in Filana Therapeutics in Q3 2022 and has held it in 15 quarters since.
- Salem Investment Counselors's Filana Therapeutics position peaked at $12K in Q3 2022.
- 19 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.